Regulation 32, National Medical Commission (Licensing of Manufacturers) Regulations, 2025 [SFR-2TY]
As at 7 September 2026. In force from 1 December 2025.
Name board.—Every manufacturer shall exhibit, at the entrance of every premises where the manufacture of drugs is carried on, a board in the local language showing his name, the number and date of his certificate of registration and the hours during which the premises are open, shall correct the board within thirty days of any change in those particulars, and shall report the correction to the Licensing Authority in Form 20 within ninety days of making it.
Defined terms in this text (0)
none
Made under this regulation, or naming it (0)
none
Cited by (0)
none
Not held (0)
none
Duties published under this regulation (0)
none